SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

Completion of ANKTIVAs first German labeling and packaging run is driving attention, signaling progress toward European commercial distribution for approved bladder-cancer use. Traders are also debating whether UAE and Saudi discussions could lead to broader lymphopenia or all-cancer access, with bullish investors citing international revenue and short-squeeze potential while skeptics await formal approvals and revenue evidence.

ProShares Trust II - ProShares UltraShort Bloomberg Crude Oil -2x Shares

ProShares UltraShort Bloomberg Crude Oil

Speculation around Iran peace talks, reopening the Strait of Hormuz, and increased oil supply is driving bets that crude prices could fall, making SCO a vehicle for short-term inverse-oil trades. Traders remain divided, with some expecting de-escalation to lift SCO while others warn that persistent disruptions could keep oil elevated; the funds daily reset, decay, and recent reverse split are also fueling debate.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Uncertainty over Auvelitys launch for Alzheimers-related agitation is driving attention, as weekly prescription growth has appeared flat or modest despite the expanded sales force. Traders debate whether samples and long-term-care data are understating demand, while others remain concerned about rising expenses, ongoing losses, and the delayed path to profitability, contributing to the low-volume selloff.

One Stop Systems, Inc. engages in the design, manufacture, and marketing of computing modules and systems targeting edge deployments. It deals with the design and manufacture of high-performance customized computer and flash arrays, in-flight entertainment, and connectivity and value-added reseller with minimal customization. The company operates through the OSS and OSS Europe segments. One Stop Systems was founded by Stephen D. Cooper and Mark Gunn in 1998 and is headquartered in Escondido, CA.

One Stop Systems Inc

Q2 results showing strong revenue growth, record bookings and raised full-year guidance are driving attention, although a one-time legal settlement produced a GAAP loss and sparked a sharp selloff. Traders remain divided between viewing the decline as an AI/small-cap sector rotation and focusing on the need for larger contracts and backlog conversion.

Root, Inc. is a technology insurance company, which engages in the provision of insurance services. It offers mobile telematics and technology platforms to segment individual risk based on complex behavioral data and customer experience to make pricing decisions and grow businesses. It provides insurance products and services in the United States. The company was founded by Alexander E. Timm and Daniel Manges in February 2015 and is headquartered in Columbus, OH.

Root Inc - Ordinary Shares - Class A

Root Inc

Recent quarterly results showing continued profitability but weak revenue and declining policies-in-force are driving debate over whether Root is prioritizing margins at the expense of growth. Bulls point to share buybacks, cash generation, and expanding embedded-insurance partnerships, while bears argue that reduced marketing and stagnant policy growth make the valuation difficult to justify.

Carnival Corp. Ltd. engages in the operation of cruise ships. It operates through the following business segments: North America Cruise Operations, Europe Cruise Operations, Cruise Support, and Tour and Others. The North America Cruise Operations segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corporation Ltd.

Carnival Corp

Uncertainty surrounding the U.S.-Iran conflict and Strait of Hormuz shipping risks is driving attention, with traders linking oil-price spikes and potential fuel-cost pressure to weakness across cruise stocks. Others point to Carnivals resilient demand, debt reduction, buybacks, dividend and low valuation as reasons to view the pullback as a buying opportunity, leaving the community split between short-term bearishness and long-term optimism.

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

A sharp rebound in PEPE and broader crypto meme-coin momentum is driving attention, with traders attributing the move to Bitcoin strength, short liquidations and possible squeeze dynamics. Others view it as a potentially artificial bounce or bull trap, citing thin volume, repeated pullbacks and PEPEs longer-term underperformance; regulatory and ETF speculation remains unconfirmed.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

A Ninth Circuit ruling that sports-related prediction contracts are bets rather than federally regulated swaps is being viewed as a regulatory win for DraftKings, potentially limiting Kalshi-style competition and strengthening licensed sportsbooks position. Traders are broadly reacting positively, though debate remains over a possible Supreme Court appeal and whether DraftKings own prediction-market expansion could ultimately cannibalize or boost its core business ahead of football season.

GLOBALFOUNDRIES, Inc. provides foundry services and manufactures semiconductors. It offers global shuttle, mask, post-fab and turnkey services. The company was founded on October 7, 2008 and is headquartered in Malta, NY.

GlobalFoundries Inc

U.S. government backing for GlobalFoundries domestic quantum manufacturing and silicon-photonics initiatives is driving attention, alongside its AI data-center and specialty-foundry positioning. The community is broadly bullish on the long-term opportunity, though traders debate whether persistent selling, low volume, and Mubadalas share sales are overshadowing the favorable developments.

Vera Therapeutics, Inc. is a clinical stage biotechnical company, which engages in the development and commercialization of transformative treatments for immunological diseases. Its product includes the TRUTAKNA injection. The company was founded by Marshall W. Fordyce in May 2016 and is headquartered in Brisbane, CA.

Vera Therapeutics Inc - Ordinary Shares - Class A

FDA accelerated approval of TRUTAKNA (atacicept) for adults with IgA nephropathy has driven attention, with traders debating the muted sell-the-news reaction and whether commercialization, upcoming kidney-function data, or competitive pressure from Otsuka and Vertex will determine the next move. Elevated short interest and takeover speculation are also fueling bullish squeeze narratives, though some traders remain concerned about efficacy and launch execution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
